8.55
+9.48%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Alpha Teknova
From its filings with the US Securities and Exchange Commission
Alpha Teknova is based in Hollister, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker TKNO. The SEC classifies its business as in vitro & in vivo diagnostic substances. In the fiscal year to 31 December 2025, it reported revenue of $40.5m and a net loss of $17.3m. At that date it held total assets of $103.6m and shareholders' equity of $68.8m.
Alpha Teknova, Inc. (referred to herein as the Company, Teknova, we, us or our) is a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Our more than 3,000 customers span the continuum of the life sciences market and include leading pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions. Our Company is built around our knowledge, methods, and know-how in our manufacturing processes and infrastructure, which are highly adaptable and configurable. These proprietary processes enable us to manufacture and deliver high-quality, custom, made-to-order products with short turnaround times and at scale, across all stages of our customers’ product development, including commercialization.
We have substantial expertise in manufacturing customer-specified formulations and have demonstrated the ability to manufacture and deliver our products to customers quickly. Due to our expertise in raw materials sourcing, chemical formulation, and quality control, developed over more than two decades, we are typically able to move a new custom product into production in a matter of weeks from order receipt. This can allow our customers to receive their products in weeks as compared to months from alternative suppliers operating in traditional production environments.
Quoted from its 10-K, filed 2 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 25 Jun 2021
- Employees
- 158
- Website
- teknova.com ↗
- Head office
- 2451 BERT DRIVE, HOLLISTER, CA, 95023
- Incorporated in
- DE
- Classification
- In Vitro & In Vivo Diagnostic Substances
- Filer status
- <br>Emerging growth company
Leadership
Pay as last reported
- Dr. Paul GrossmanNon-Executive Chairman of the Board
- Mr. Stephen GunstreamPresident, Chief Executive Officer, Director, since 2019$932,301
- Mr. Matthew LowellChief Financial Officer$591,500
- Mr. Damon TerrillChief Compliance Officer, General Counsel$570,898
- Ms. Irene DavisDirector, since 2015$388,704
- Alex HerzickDirector
- Mr. J. Matthew MackowskiDirector
- Ms. Martha DemskiIndependent Director$93,300
- Ms. Brett RobertsonIndependent Director$90,800
- Mr. Alexander VosIndependent Director$85,800
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 28
- Environment
- 5
- Social
- 31
- Governance
- 48
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Alpha Teknova Inc has a strong reputation in the industry due to its high-quality products and excellent customer service. The company's innovative and technologically advanced solutions give it a competitive edge in the market. Additionally, Alpha Teknova Inc has a talented and experienced team, which enables them to deliver customized solutions to meet client requirements effectively.
Weaknesses
- One potential weakness for Alpha Teknova Inc is its limited global presence, which could impact its ability to tap into international markets fully. Additionally, the company might face hurdles in the form of resource constraints, such as limited funding for research and development, as well as the need for continuous technological advancements to stay ahead of competitors.
Opportunities
- Alpha Teknova Inc has the opportunity to expand its market reach by exploring new geographical areas and targeting untapped customer segments. This could be achieved through strategic partnerships or acquisitions. The growing demand for advanced technology solutions in various industries presents a significant opportunity for Alpha Teknova Inc to introduce innovative products and capture a larger market share.
Threats
- Alpha Teknova Inc may face increased competition from both established players and emerging startups in the industry. Rapid technological advancements also pose a threat as the company needs to constantly adapt and stay ahead to avoid becoming obsolete. Additionally, factors like changing regulations and economic instability could impact the company's operations and profitability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.